Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis In Romania.
Authors: Codreanu, C.1, Mogosanu, C.1, Joita, M.2, Purcaru, O.3
Source: Value in Health. Nov2014, Vol. 17 Issue 7, pA379-A379. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2014.08.2608